Does the PI3K pathway promote or antagonize regulatory T cell development and function?

被引:36
|
作者
Soond, Dalya R. [1 ]
Slack, Elizabeth C. M. [1 ,2 ]
Garden, Oliver A. [2 ]
Patton, Daniel T. [3 ]
Okkenhaug, Klaus [1 ]
机构
[1] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England
[2] Univ London Royal Vet Coll, Dept Vet Clin Sci, Regulatory T Cell Lab Infect Immun Res Grp, London, England
[3] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada
来源
FRONTIERS IN IMMUNOLOGY | 2012年 / 3卷
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
Akt; autoimmunity; Foxo; inflammation; mTOR; PI3K; T cell; Treg; PHOSPHOINOSITIDE 3-KINASE P110-DELTA; FOXP3; EXPRESSION; CUTTING EDGE; NEGATIVE REGULATION; P110-GAMMA ISOFORM; B-CELL; DIFFERENTIATION; INDUCTION; EFFECTOR; GENERATION;
D O I
10.3389/fimmu.2012.00244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) prevent autoimmunity and nflammation by suppressing the activation of other T cells and antigen presenting cells. The role of phosphoinositide 3-kinase (PI3K) signaling in Treg is controversial. Some studies suggest that inhibition of the PI3K pathway is essential for the development of Tregs whereas other studies have shown reduced Treg numbers and function when PI3K activity is suppressed. Here we attempt to reconcile the different studies that have explored PI3K and the downstream effectors Akt, Foxo, and mTOR in regulatory T cell development and function and discuss the implications for health and therapeutic intervention.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
    Pompura, Saige L.
    Dominguez-Villar, Margarita
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (06) : 1065 - 1076
  • [2] ICOS-dependent PI3K signaling in regulatory T cell development and function
    Mittelsteadt, Kristen L.
    Sullivan, Jenna M.
    Campbell, Daniel J.
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196
  • [3] Role of class IA PI3K in regulatory T cell function
    Fujii, Hideki
    Matsuda, Satoshi
    Ohtani, Masashi
    Koyasu, Shigeo
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188
  • [4] A requirement for PI3K in γδ T cell development
    Sumaria, N.
    Pang, D. J.
    Grandjean, C. L.
    Neves, J. F.
    Stoenchev, K. V.
    Silva-Santos, B.
    Pennington, D. J.
    [J]. IMMUNOLOGY, 2013, 140 : 160 - 160
  • [5] Critical roles of the PI3K/Akt signaling pathway in T cell development
    Juntilla, Marisa A.
    Koretzky, Guy A.
    [J]. IMMUNOLOGY LETTERS, 2008, 116 (02) : 104 - 110
  • [6] Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
    Sasaki, T
    Irie-Sasaki, J
    Jones, RG
    Oliveira-dos-Santos, AJ
    Stanford, WL
    Bolon, B
    Wakeham, A
    Itie, A
    Bouchard, D
    Kozieradzki, I
    Joza, N
    Mak, TW
    Ohashi, PS
    Suzuki, A
    Penninger, JM
    [J]. SCIENCE, 2000, 287 (5455) : 1040 - 1046
  • [7] Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
    Mayuko Uehara
    Martina M. McGrath
    Shunsuke Ohori
    Zhabiz Solhjou
    Naima Banouni
    Sujit Routray
    Catherine Evans
    Jonathan P. DiNitto
    Abdallah Elkhal
    Laurence A. Turka
    Terry B. Strom
    Stefan G. Tullius
    David G. Winkler
    Jamil Azzi
    Reza Abdi
    [J]. Nature Communications, 8
  • [8] Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
    Uehara, Mayuko
    McGrath, Martina M.
    Ohori, Shunsuke
    Solhjou, Zhabiz
    Banouni, Naima
    Routray, Sujit
    Evans, Catherine
    DiNitto, Jonathan P.
    Elkhal, Abdallah
    Turka, Laurence A.
    Strom, Terry B.
    Tullius, Stefan G.
    Winkler, David G.
    Azzi, Jamil
    Abdi, Reza
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [9] The role of the PI3K signaling pathway in CD4+ T cell differentiation and function
    Han, Jonathan M.
    Patterson, Scott J.
    Levings, Megan K.
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [10] Evaluation of the PI3K pathway in peripheral t-cell lymphoma
    Lim, S. T.
    Nairismagi, M-L.
    Tan, S. H.
    Thit, E. E.
    Politz, O.
    Liu, N.
    Ong, C. K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28